Pharmaceuticals, Biotechnology and Life Sciences
Immediate access to UK medical cannabis market LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical…
Expanded license creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…
Expanded licence creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its…
Bio-Rad has bagged clearance from the U.S. Food and DrugAdministration (FDA) for its IH-500, an automated randomaccess system for blood typing and screening.
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after…
Unprecedented clinical results for DaxibotulinumtoxinA for Injection(DAXI), Revance’s long-acting neuromodulator, were highlighted at the 17thAesthetics & Anti-Aging Medical World Congress in Monte-Carlo
Tricida has closed public offering of common stock and full exercise of underwriters’ option to ourchase additional shares
Azitra will be presenting results from the joint researchshowing the successful genetic engineering of the common skin bacterium, Staphylococcusepidermidis, to produce high levels of functional LEKTI protein, aprotease inhibitor involved in regulating the rate of skin loss.
SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a San Francisco based technology company and Pharmacy Benefit Manager (PBM), today released the company’s public comment…